Oncologix Tech Inc. (OCLG)
Oncologix Tech Inc. operates in the Medical - Diagnostics & Research industry of the Healthcare sector, headquartered in Lafayette, LA, US. The stock last traded at $0.00, up 0.00% on the session, giving a market capitalisation of $73,662. On trailing twelve-month figures it carries a trailing P/E of -0.03, a net margin of -83.2%. Its beta of 0.00 implies it has historically moved less than the broad market.
Oncologix Tech, Inc. is a biopharmaceutical company whose main products include DNAGO and genomego which provides clinical genetic testing on all 20,000+ genes encompassing over 7,000 rare genetic diseases. It also previously operated in personal home care services and the manufacturing and distribution of medical technologies. The company was formerly known as BestNet Communications Corp. and changed its name to Oncologix Tech, Inc. in January 2007.
Oncologix Tech Inc. is most often compared with the following Healthcare names: